Ipca Laboratories Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
36000.63 Cr.
|
P/BV
|
5.37
|
Book Value (Rs.)
|
264.10
|
52 Week High/Low (Rs.)
|
1756/1052
|
FV/ML
|
1/1
|
P/E(X)
|
65.77
|
Bookclosure
|
25/11/2024
|
EPS (Rs.)
|
21.57
|
Div Yield (%)
|
0.28
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 7622.41 | 6206.85 | 5766.46 | 5366.00 | 4588.38 |
Other Operating Revenues | 82.63 | 37.47 | 63.33 | 53.99 | 60.33 |
Total Operating Revenues | 7705.04 | 6244.32 | 5829.79 | 5419.99 | 4648.71 |
| | | | | |
Other Income | 124.77 | 125.62 | 66.57 | 62.84 | 67.00 |
Total Revenue | 7829.81 | 6369.94 | 5896.36 | 5482.83 | 4715.71 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 2216.32 | 1708.65 | 1664.20 | 1597.14 | 1460.37 |
Purchase Of Stock-In Trade | 490.07 | 497.19 | 480.30 | 325.95 | 359.88 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -130.64 | 100.67 | -129.65 | -194.79 | -176.12 |
Employee Benefit Expenses | 1708.43 | 1287.64 | 1177.39 | 1013.57 | 921.23 |
Finance Costs | 138.27 | 45.54 | 7.69 | 9.04 | 16.50 |
Depreciation And Amortisation Expenses | 357.24 | 261.56 | 232.42 | 209.17 | 210.50 |
Other Expenses | 2099.70 | 1723.40 | 1328.29 | 1133.77 | 1176.65 |
Total Expenses | 6879.39 | 5624.65 | 4760.64 | 4093.85 | 3969.01 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 950.42 | 745.29 | 1135.72 | 1388.98 | 746.70 |
| | | | | |
Exceptional Items | -107.75 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit/Loss Before Tax | 842.67 | 745.29 | 1135.72 | 1388.98 | 746.70 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 313.24 | 230.14 | 207.01 | 248.65 | 140.59 |
Deferred Tax | 3.28 | 23.00 | 17.26 | -8.50 | -5.78 |
Tax For Earlier Years | -3.06 | 0.22 | 0.50 | -0.01 | 0.52 |
Total Tax Expenses | 313.46 | 253.36 | 224.77 | 240.14 | 135.33 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 529.21 | 491.93 | 910.95 | 1148.84 | 611.37 |
| | | | | |
Profit/Loss From Continuing Operations | 529.21 | 491.93 | 910.95 | 1148.84 | 611.37 |
| | | | | |
Profit/Loss For The Period | 529.21 | 491.93 | 910.95 | 1148.84 | 611.37 |
| | | | | |
Minority Interest | 24.43 | -7.67 | -5.71 | -1.13 | 2.76 |
Share Of Profit/Loss Of Associates | -6.29 | -12.94 | -21.16 | -7.70 | -7.81 |
Consolidated Profit/Loss After MI And Associates | 547.35 | 471.32 | 884.08 | 1140.01 | 606.32 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 25.82 | 18.58 | 34.85 | 45.01 | 47.77 |
Diluted EPS (Rs.) | 21.57 | 18.58 | 34.85 | 45.01 | 47.73 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 50.74 | 101.48 | 101.48 | 101.48 | 101.08 |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 20.77 |